| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Amgen (NASDAQ: AMGN) today announced new results showing the positive overall survival (OS) findings from the final analysis of the Phase 3 ASPIRE trial. The study met the key secondary endpoint...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today the first reported data of the investigational agent gilteritinib from the ongoing, open-label,...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4...
-
Dec 11, 2017CES 2018 Exhibitor News releases, photos and supporting content
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets,...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2017 Prescription for Success Healthcare Conference on December 14, 2017 at 3:30 p.m....
